Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects
Clinical trial NCT06084663 · COMPLETED
Trial details
- NCT number
- NCT06084663
- Sponsor
- Humanis Saglık Anonim Sirketi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2023-02-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.